UBC is a proven leader in helping our clients gain the best position for market access through the development and execution of research-based strategies and tactics. Our goal is to ensure that when your product launches, you will be equipped for success.
As part of this process, we partner with our drug, biological, device and diagnostic manufacturer clients during the pre-launch development phase to assess the reimbursement landscape and develop payer launch strategies & tactics.
A complete reimbursement and pricing assessment might include:
- Payer mix analyses coverage and payment landscapes
- Coding and billing analyses
- Analogue pricing analyses
- Payer and provider market research
- Advisory boards
- Medicare Part D formulary access analysis for self-administered drugs serving the Medicare population
All of this research drives the development of a strategic launch-to-payer plan.
UBC is also highly skilled in developing reimbursement educational materials for payers, providers, sales representatives and specialty teams. When needed, we can write and support coding applications.
To support your customers and help you remain competitive in the market, UBC operates reimbursement support and Patient Assistance Program (PAP) hotlines. UBC has extensive experience supporting products that require high levels of case management and uses payer advocacy networks to improve coverage policy and secure reimbursement.